Bay Colony Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.6M | Buy |
22,834
+2,700
| +13% | +$189K | 0.22% | 90 |
|
|
2025
Q1 | $1.49M | Buy |
20,134
+668
| +3% | +$49.3K | 0.23% | 94 |
|
|
2024
Q4 | $1.28M | Sell |
19,466
-2,115
| -10% | -$139K | 0.19% | 115 |
|
|
2024
Q3 | $1.68M | Buy |
21,581
+700
| +3% | +$54.5K | 0.25% | 86 |
|
|
2024
Q2 | $1.63M | Buy |
20,881
+1,446
| +7% | +$113K | 0.27% | 83 |
|
|
2024
Q1 | $1.32M | Buy |
19,435
+3,796
| +24% | +$257K | 0.23% | 91 |
|
|
2023
Q4 | $1.05M | Buy |
15,639
+1,201
| +8% | +$80.9K | 0.21% | 111 |
|
|
2023
Q3 | $978K | Buy |
14,438
+11,440
| +382% | +$775K | 0.24% | 101 |
|
|
2023
Q2 | $215K | Hold |
2,998
| – | – | 0.05% | 306 |
|
|
2023
Q1 | $207K | Sell |
2,998
-35
| -1% | -$2.42K | 0.05% | 301 |
|
|
2022
Q4 | $206K | Buy |
+3,033
| New | +$206K | 0.05% | 324 |
|
|
2022
Q3 | – | Sell |
-3,245
| Closed | -$215K | – | 327 |
|
|
2022
Q2 | $215K | Sell |
3,245
-695
| -18% | -$46K | 0.05% | 303 |
|
|
2022
Q1 | $261K | Buy |
+3,940
| New | +$261K | 0.06% | 290 |
|
|
2018
Q3 | – | Sell |
-70
| Closed | -$2K | – | 262 |
|
|
2018
Q2 | $2K | Buy |
+70
| New | +$2K | ﹤0.01% | 850 |
|